http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_61a9a4e75d783a24eec2a7a79def861b
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Leo Di Leo |
| name | Angelo Di Leo |
| given-name | Angelo Di Angelo |
| organization-name | ‘Sandro Pitigliani‘ Medical Oncology Unit, Hospital of Prato, Istituto Toscano Tumori, Piazza Ospedale 2, 59100, Prato, Italy. Divisione di Oncologia Medica « B », Istituto Nazionale per lo Studio e la Cura dei Tumori, Milano Sandro Pitigliani Department of Medical Oncology, Hospital of Prato, Prato, 59100, Italy 5Sandro Pitigliani Medical Oncology Unit, Prato, Italy; ‘Sandro Pitigliani’ Medical Oncology Department, Hospital of Prato, Istituto Toscano Tumori, 50139 Firenze, Prato, Italy From the Hospital of Prato, Prato, Italy; Centre Hospitalier Universitaire Sart Tilman, Liège; AZ. Klina, Brasschaat, Belgium; Charles University, Prague, Czech Republic; Instituto Nacional del Cáncer, Santiago, Chile; Dnipropetrovsk Municipal Clinical Hospital, Dnipropetrovsk, Ukraine; Republican Clinical Oncological Center, Kazan; Medical Radiological Science Center, Obninsk; Russian Cancer Research Centre, Moscow, Russia; Hospital Nossa Senhora da Conceição, Porto Alegre, Brazil; Kansas City Cancer... “Sandro Pitigliani” Translational Research Unit, Hospital of Prato-AUSL Toscana Centro, Istituto Toscano Tumori, Prato, Italy; “Sandro Pitigliani” Medical Oncology Department, Hospital of Prato-AUSL Toscana Centro, Istituto Toscano Tumori, Prato, Italy Department of Oncology, Hospital of Prato, Istituto Toscani Tumori, Florence, Italy (Division of Medical Oncology B, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan) for the International Breast Cancer Study Group (IBCSG) ‘Sandro Pitigliani’ Medical Oncology Department, Hospital of Prato, Via Suor Niccolina 20, Prato 59100, Italy “Sandro Pitigliani” Medical Oncology Unit, Department of Oncology, “Misericordia e Dolce” Hospital, Prato; ‘Sandro Pitigliani’ Medical Oncology Department, Hospital of Prato, Istituto Toscano Tumori, Prato 59100, Italy "Sandro Pitigliani" Medical Oncology Department, Hospital of Prato, Via Suor Niccolina 20, Prato, 59100, Italy. Electronic address: angelo.dileo@uslcentro.toscana.it. 1Jules Bordet Institute, Brussels, Belgium; “Sandro Pitigliani” Medical Oncology Unit, Prato, Italy “Sandro Pitigliani” Medical Oncology Unit, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy UO Oncologia Medica “Sandro Pitigliani”, Ospedale Misericordia e Dolce, Azienda USL 4, Prato Sandro Pitigliani Medical Oncology Department, Hospital of Prato, Istituto Toscano Tumori, 59100, Prato, Italy Medical Oncology Unit, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. adileo@usl4.toscana.it Ann H. Partridge, Dana-Farber Cancer Institute; Steven E. Come, Beth Israel Deaconess Medical Center; Beverly Moy, Massachusetts General Hospital, Boston, MA; R. Bryan Rumble, American Society of Clinical Oncology, Alexandria; Michael A. Danso, Virginia Oncology Associates, Norfolk, VA; Lisa A. Carey, University of North Carolina, Chapel Hill, NC; Nancy E. Davidson, University of Pittsburgh Cancer Institute/University of Pittsburgh Medical Center, Pittsburgh, PA; Angelo Di Leo, Sandro Pitigliani Medical... 1Translational Research Unit and 1“Sandro Pitigliani” Medical Oncology Department, Hospital of Prato, Azienda USL Toscana Centro, Prato, Italy. Department of Chemotherapy, Jules Bordet Institute, Brussels Sherene Loi, Nicolas Sirtaine, Roberto Salgado, Françoise Van Eenoo, Ghizlane Rouas, Stefan Michiels, Martine J. Piccart, and Christos Sotiriou, Institut Jules Bordet, Brussels; Fanny Piette and Emmanuel Quinaux, International Drug Development Institute, Louvain-la-Neuve, Belgium; Giuseppe Viale, University of Milan, Milan; Angelo Di Leo, Hospital of Prato, Prato, Italy; Prudence Francis, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australian and New Zealand Breast Cancer Trials Group, Newcastle,... "Sandro Pitigliani" Medical Oncology Unit, Hospital of Prato, Instituto Toscano Tumori, Via Suor Niccolina 20, 59100, Prato, Italy. adileo@usl4.toscana.it. Sandro Pitigliani Medical Oncology Unit, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy From the Sandro Pitigliani Medical Oncology Unit, Hospital of Prato; Istituto Toscano Tumori, Prato; and the Center for Magnetic Resonance, Scientific Pole, University of Florence, Sesto Fiorentino, Florence, Italy Hospital of Prato–AUSL Toscana Centro, Prato, Italy Hospital of Prato, Istituto Toscano Tumori, Prato, Italy From the “Sandro Pitigliani” Medical Oncology Unit, Prato, Italy; Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru; Allama Iqbal Medical College, Lahore, Pakistan; Riga Eastern University Hospital Latvian Oncology Centre, Rīga, Latvia; National Cancer Institute, Rio De Janeiro, Brazil; Medicine Development Center Oncology, GlaxoSmithKline, Collegeville, PA; Geffen School of Medicine at University of California, Los Angeles; and Norris Comprehensive Cancer Center, University of Southern... Chemotherapy Unit, Institut Jules Bordet, Brussels, Belgium Karen A. Gelmon, David G. Huntsman, and Samuel Aparicio, British Columbia Cancer Agency, Vancouver Cancer Centre, Vancouver; Susan L. Ellard, British Columbia Cancer Agency, Cancer Centre for the Southern Interior, Kelowna, British Columbia; Julie Lemieux, Centre Hospitalier Affilié Hopital Du St Sacrement, Quebec City, Quebec; Lois E. Shepherd, Dora Nomikos, Judith-Anne W. Chapman, and Wendy R. Parulekar, NCIC Clinical Trials Group, Queen's University, Kingston; Susan Dent, Ottawa Health Research... Chee Khoon Lee, Lucy Davies, Val J. Gebski, Sarah J. Lord, Ian Marschner, and John Simes, University of Sydney; Sarah J. Lord, University of Notre Dame; Ian Marschner, Macquarie University; Paul de Souza, University of Western Sydney, Sydney, New South Wales; Sherene Loi, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; Angelo Di Leo, Hospital of Prato, Istituto Toscano Tumori, Italy; Stephen Johnston, Royal Marsden Hospital, London; David Cameron, University of Edinburgh, Edinburgh, United... “Sandro Pitigliani” Medical Oncology Department, Hospital of Prato, Prato, Italy 1“Sandro Pitigliani” Medical Oncology Department, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. Jules Bordet Institute, Brussels, Belgium From the Institut Jules Bordet; Machine Learning Group, Université Libre de Bruxelles; Hôpitaux Iris Sud–Site Etterbeek-Ixelles; Hopital Saint-Pierre, Brussels; Clinique Saint-Pierre, Ottignies; Clinique Ste Elisabeth, Namur; International Drug Development Institute, Louvain-La-Neuve, Belgium; Hospital of Prato, Prato, Italy; Institut Gustave Roussy, Villejuif, France; Centre Hospitalier du Luxembourg, Luxembourg, Luxembourg; and University of Texas MD Anderson Cancer Center, Houston, TX. (Division of Medical Oncology B and Gynecological Oncology, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy) Hospital Nossa Senhora da Conceição, Brazil Matthew P. Goetz, Mayo Clinic, Rochester, MN; Masakazu Toi, Kyoto University, Kyoto, Japan; Mario Campone, Institut de Cancerologie de l’Ouest, Angers Cedex; Olivier Trédan, Centre Léon Bérard, Lyon; Nawel Bourayou, Eli Lilly, Paris, France; Joohyuk Sohn, Yonsei Cancer Center, Seoul; In Hae Park, National Cancer Center, Goyangsi, South Korea; Shani Paluch-Shimon, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel; Jens Huober, University of Ulm, Ulm, Germany; Shin-Cheh Chen, Chang Gung University... Sandro Pitigliani Medical Oncology Unit, Hospital of Prato, Instituto Toscano Tumori, Prato, Italy “Sandro Pitigliani” Translational Research Unit, Hospital of Prato, Prato, Italy; “Sandro Pitigliani” Medical Oncology Department, Hospital of Prato, Prato, Italy Hospital of Prato Prato Italy From the Jules Bordet Institute, Belgian and Luxembourg Cooperative Centers, and Pharmacia-Upjohn, Brussels, Belgium. Sandro Pitigliani” Department of Oncology Ospedale Santo Stefano Prato Italy From the Sandro Pitigliani Medical Oncology Department, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy; Translational Research Unit, Department of Medical Oncology, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. Sandro Pitigliani Medical Oncology Department Hospital of Prato Prato Italy John M.S. Bartlett, Ontario Institute for Cancer Research; Frances P. O'Malley, St Michael's Hospital; Kathleen I. Pritchard, Sunnybrook Odette Cancer Centre and University of Toronto, Toronto; John M.S. Bartlett, Frances P. O'Malley, and Lois E. Shepherd, National Cancer Institute of Canada Clinical Trials Group; Lois E. Shepherd, Queen's University, Kingston, Canada; John M.S. Bartlett, Alison F. Munro, and David A. Cameron, University of Edinburgh, Edinburgh; Christopher C. McConkey, Janet A. Dunn,... 4Translational Research Unit, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy.; 5"Sandro Pitigliani" Medica Oncology Unit, Istituto Toscano Tumori, Prato, Italy. Authors' Affiliations: 1Arizona Cancer Center, Tucson, Arizona; 2Medicine Development Centre Oncology, GlaxoSmithKline, Collegeville, Pennsylvania; 3Norris Cancer Center, University of Southern California, Los Angeles, California; and 4Sandro Pitigliani Medical Oncology Unit, Prato, Italy From the Geffen School of Medicine at UCLA; Norris Cancer Center, University of Southern California, Los Angeles, CA; Medicine Development Centre Oncology, GlaxoSmithKline, Collegeville, PA; and the Sandro Pitigliani Medical Oncology Unit, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. Hospital of Prato-AUSL Toscana Centro and International Breast Cancer Study Group, Prato, Italy Hospital of Prato–AUSL Toscana Centro Prato Italy Sandro Pitigliani Medical Oncology Department, Hospital of Prato, Prato, Italy From the Geffen School of Medicine at University of California, Los Angeles; Norris Cancer Center, University of Southern California, Los Angeles, CA; Medicine Development Centre Oncology, GlaxoSmithKline, Middlesex, United Kingdom; and Sandro Pitigliani Medical Oncology Unit, Prato, Italy. Department of Oncology, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy; Otto Metzger-Filho, Evandro de Azambuja, Kamal S. Saini, Sherene Loi, Hatem A. Azim Jr, Christos Sotiriou, and Martine Piccart-Gebhart, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium; Andrew Tutt and Paul Ellis, King's College London, Guy's Campus, London; Judith M. Bliss, Institute of Cancer Research, Sutton; Ian Bradbury, Frontier Science, Kincraig, Scotland, United Kingdom; Giuseppe Viale, European Institute of Oncology, University of Milan, Milan; Angelo Di Leo, Hospital of... Hospital of Prato-AUSL Toscana Centro, Prato, Italy 6Medical Oncology Unit, Hospital of Prato, Prato, Italy |
Incoming Links
Total number of triples: 267.